The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Worldwide Emergence of Extensively Drug-resistant Tuberculosis
Open accessAbstract
Mycobacterium tuberculosis strains that are resistant to an increasing number of second-line drugs used to treat multidrug-resistant tuberculosis (MDR TB) are becoming a threat to public health worldwide. We surveyed the Network of Supranational Reference Laboratories for M. tuberculosis isolates that were resistant to second-line anti-TB drugs during 2000-2004. We defined extensively drug-resistant TB (XDR TB) as MDR TB with further resistance to > or = 3 of the 6 classes of second-line drugs. Of 23 eligible laboratories, 14 (61%) contributed data on 17,690 isolates, which reflected drug susceptibility results from 48 countries. Of 3,520 (19.9%) MDR TB isolates, 347 (9.9%) met criteria for XDR TB. Further investigation of population-based trends and expanded efforts to prevent drug resistance and effectively treat patients with MDR TB are crucial for protection of public health and control of TB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
Global Tuberculosis Control 2011, WHO Report 2011
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022
Edlin, B. R., Tokars, J. I., Grieco, M. H., Crawford, J. T., Williams, J., Sordillo, E. M., Ong, K. R., Kilburn, J. O., Dooley, S. W., Castro, K. G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206043262302 · Cited by 861
Treatment of Multidrug-Resistant Tuberculosis
Wood, A. J. J., & Iseman, M. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309093291108 · Cited by 706
Global Incidence of Multidrug‐Resistant Tuberculosis
Zignol, M., Hosseini, M. S., Wright, A., Weezenbeek, C. L., Nunn, P., Watt, C. J., Williams, B. G., & Dye, C. (2006) · The Journal of Infectious Diseases · doi:10.1086/505877 · Cited by 524
Self-citation(2006) · PsycEXTRA Dataset · doi:10.1037/e566482006-002 · Cited by 513
Multidrug-resistant Tuberculosis
Dooley, S. W., Jarvis, W. R., Marione, W. J., & Snider, D. E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-257 · Cited by 376
Frieden, T. R. (1996) · JAMA · doi:10.1001/jama.276.15.1229 · Cited by 295
Leimane, V., Riekstina, V., Holtz, T. H., Zarovska, E., Skripconoka, V., Thorpe, L. E., Laserson, K. F., & Wells, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17786-1 · Cited by 279
Self-citationMaus, C. E., Plikaytis, B. B., & Shinnick, T. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3192-3197.2005 · Cited by 273
(1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470110027006 · Cited by 272
Present aspects of bacterial resistance in tuberculosis.
Canetti, G. (1965) · PubMed · doi:10.1164/arrd.1965.92.5.687 · Cited by 211
Coronado, V. G., Beck-Sague, C. M., Hutton, M. D., Davis, B. J., Nicholas, P., Villareal, C., Woodley, C. L., Kilburn, J. O., Crawford, J. T., Frieden, T. R., et al. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.4.1052 · Cited by 200
Frieden, T. R. (1996) · JAMA · doi:10.1001/jama.1996.03540150031027 · Cited by 199
Heifets, L. B., & Cangelosi, G. A. (1999) · PubMed · Cited by 144
Frieden, T. R., Sherman, L. F., Maw, K. L., Fujiwara, P. I., Crawford, J. T., Nivin, B., Sharp, V., Hewlett, D., Brudney, K. F., Alland, D., et al. (1996) · PubMed · Cited by 141
Pfyffer, G. E., Bonato, D. A., Ebrahimzadeh, A., Gross, W. M., Hotaling, J. E., Kornblum, J. S., Laszlo, A., Roberts, G. D., Salfinger, M., Wittwer, F., et al. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.10.3179-3186.1999 · Cited by 133
Krüüner, A., Yates, M. D., & Drobniewski, F. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.811-818.2006 · Cited by 126
Self-citationIncreasing transparency in partnerships for health – introducing the Green Light Committee
Gupta, R., Cegielski, J. P., Espinal, M., Henkens, M., Kim, J. Y., Weezenbeek, C. S. B. L.-V., Lee, J., Raviglione, M. C., Suarez, P. G., & Varaine, F. (2002) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2002.00960.x · Cited by 117
Self-citationOutbreak of multidrug-resistant tuberculosis at a hospital--New York City, 1991.
(1993) · PubMed · Cited by 45
Clinical mismanagement and other factors producing antituberculosis drug resistance
Pablos-Méndez, A., & Lessnau, K. (2000) · Resurgent and emerging infectious diseases · doi:10.1007/978-94-011-4084-3_5 · Cited by 15
Cited by
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., van Soolingen, D., Jensen, P., & Bayona, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60410-2 · Cited by 1,018
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Lawn, S. D., & Zumla, A. I. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62173-3 · Cited by 751
Metadata
- Authors
- Shah, N. S., Wright, A., Bai, G.-H., Barrera, L., Boulahbal, F., Martín-Casabona, N., Drobniewski, F., Gilpin, C., Havelková, M., Lepe, R., Lumb, R., Metchock, B., Portaels, F., Rodrigues, M. F., Rüsch-Gerdes, S., Van Deun, A., Vincent, V., Laserson, K., Wells, C., & Cegielski, J. P.
- Venue
- Emerging Infectious Diseases
- Published
- 2007-03
- Volume
- 13
- Issue
- 3
- Pages
- 380-387
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2127258416
- Cited by
- 583
- References
- 21
- FWCI
- 38.39
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.